NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Diego, California, USA.
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Aliment Pharmacol Ther. 2023 Jul;58(2):229-237. doi: 10.1111/apt.17564. Epub 2023 Jun 2.
Magnetic resonance imaging-proton density fat fraction (MRI-PDFF) is an excellent biomarker for the non-invasive quantification of hepatic steatosis.
To examine clinical and histologic factors associated with discordance between steatosis grade determined by histology and MRI-PDFF in patients with non-alcoholic fatty liver disease (NAFLD) METHODS: We included 728 patients with biopsy-proven NAFLD from UC San Diego (n = 414) and Yokohama City University (n = 314) who underwent MRI-PDFF and liver biopsy. Patients were stratified by steatosis, and matched with MRI-PDFF cut-points for each steatosis grade: 0 (MRI-PDFF < 6.4%), 1 (MRI-PDFF: 6.4%-17.4%), 2 (MRI-PDFF: 17.4%-22.1%), 3 (MRI-PDFF ≥ 22.1%). Primary outcome was major discordance defined as ≥2 steatosis grade difference determined by histology and MRI-PDFF.
Mean (±SD) age and BMI were 55.3 (±13.8) years and 29.9 (±4.9) kg/m , respectively. The distributions of histology and MRI-PDFF-determined steatosis were 5.5% grade 0 (n = 40), 44.8% 1 (n = 326, 44.8%), 33.9% 2 (n = 247), and 15.8% 3 (n = 115) vs. 23.5% grade 0 (n = 171), 49.7% 1 (n = 362), 12.9% 2 (n = 94), and 13.9% 3 (n = 101). Major discordance rate was 6.6% (n = 48). Most cases with major discordance had greater histology-determined steatosis grade (n = 40, 88.3%), higher serum AST and liver stiffness, and greater likelihood of fibrosis ≥2, ballooning ≥1 and lobular inflammation ≥2 (all p < 0.05).
Histology overestimates steatosis grade compared to MRI-PDFF. Patients with advanced NASH are likely to be upgraded on steatosis grade by histology. These data have important implications for steatosis estimation and reporting on histology in clinical practice and trials, especially in patients with stage 2 fibrosis.
磁共振质子密度脂肪分数(MRI-PDFF)是一种出色的生物标志物,可用于无创定量肝脂肪变性。
检查与非酒精性脂肪性肝病(NAFLD)患者肝活检确定的脂肪变性程度与 MRI-PDFF 之间不一致相关的临床和组织学因素。
我们纳入了来自加利福尼亚大学圣地亚哥分校(n=414)和横滨市立大学(n=314)的 728 名经活检证实的 NAFLD 患者,他们接受了 MRI-PDFF 和肝活检。根据脂肪变性程度对患者进行分层,并与每个脂肪变性等级的 MRI-PDFF 切点相匹配:0(MRI-PDFF<6.4%)、1(MRI-PDFF:6.4%-17.4%)、2(MRI-PDFF:17.4%-22.1%)、3(MRI-PDFF≥22.1%)。主要结局是由组织学和 MRI-PDFF 确定的脂肪变性程度差异≥2 级的主要差异。
平均(±SD)年龄和 BMI 分别为 55.3(±13.8)岁和 29.9(±4.9)kg/m2。组织学和 MRI-PDFF 确定的脂肪变性分布为 5.5%为 0 级(n=40)、44.8%为 1 级(n=326,44.8%)、33.9%为 2 级(n=247)和 15.8%为 3 级(n=115),而 23.5%为 0 级(n=171)、49.7%为 1 级(n=362)、12.9%为 2 级(n=94)和 13.9%为 3 级(n=101)。主要差异率为 6.6%(n=48)。大多数主要差异病例的组织学确定的脂肪变性等级更高(n=40,88.3%),血清 AST 和肝硬度更高,纤维化≥2 级、气球样变≥1 级和肝小叶炎症≥2 级的可能性更大(均 P<0.05)。
与 MRI-PDFF 相比,组织学高估了脂肪变性程度。患有晚期 NASH 的患者其脂肪变性等级可能通过组织学检查得到升级。这些数据对临床实践和试验中脂肪变性的估计和报告具有重要意义,尤其是在 2 级纤维化的患者中。